Ohio Public Employees Retirement System (OPERS)
AIMT

Ohio Public Employees Retirement System (OPERS)’s Aimmune Therapeutics AIMT Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36,000
Closed -$1.24M – 2033
2020
Q3 		$1.24M Buy
+36,000
New +$767K 0.01% 1040

Ohio Public Employees Retirement System (OPERS)'s AIMT Position: Q4 2020 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 36,000 shares — an estimated $1.24M sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $1.24M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 36,000 Aimmune Therapeutics shares in Q4 2020, an estimated $1.24M.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • Ohio Public Employees Retirement System (OPERS)'s Aimmune Therapeutics position peaked at $1.24M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2020, filed 12 Feb 2021.